Back to Search Start Over

Synergistic Antitumor Activity of Alnuctamab (ALNUC; BMS-986349; CC-93269), a BCMA 2+1 T Cell Engager (TCE), and Celmod Agents in Multiple Myeloma (MM) Preclinical Models

Authors :
Bruno Paiva
Bonny Gaffney
Kelven Burnett
Paola Castiglioni
Michael Angelo
Daniel W. Pierce
Isaac W. Boss
Source :
Blood. 140:7054-7055
Publication Year :
2022
Publisher :
American Society of Hematology, 2022.

Details

ISSN :
15280020 and 00064971
Volume :
140
Database :
OpenAIRE
Journal :
Blood
Accession number :
edsair.doi...........46041e35588d900d78d2238ecd3ae199
Full Text :
https://doi.org/10.1182/blood-2022-157987